Gates Foundation, Serum Institute to Partner to Make COVID-19 Vaccine Affordable
The candidate vaccines will be priced at $3 per dose and made available in 92 countries
On Friday, the Serum Institute of India said it would receive $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make 100 million COVID-19 vaccine doses for India and other emerging economies as early as 2021.
The candidate vaccines, including those from AstraZeneca and Novavax, will be priced at $3 per dose and will be made available in 92 countries in GAVI's COVAX Advance Market Commitment (AMC), the company said in a statement.
The Gates Foundation will provide the funds to GAVI, which will be used to support Serum Institute. GAVI, backed by the Gates Foundation, is a public-private global health partnership with the goal of increasing access to immunization in poor countries.
Please select this link to read the complete article from NDTV.